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Prospective memory (PM) is defined as remembering when an action needs to take 
place following a cue (event-based or time-based). Alzheimer’s Disease (AD) 
patients have an impairment in PM and almost 50% of patients with mild cognitive 
impairment (MCI) are expected to develop AD. Recent research has focused on a 
potential pre-MCI stage named Subjective Cognitive Decline (SCD) in which subjects 
perform similar to healthy individuals in standard tests yet declare a decline in their 
everyday memory functioning. We propose that PM might provide a more valuable 
insight into individual’s everyday memory functioning, which is not necessarily 
reflected in standard tests. Furthermore, neuroimaging studies show that atrophy in 
specific brain regions (e.g. rostral prefrontal cortex) is linked with impairment in PM. 
This study aimed to investigate the role of PM tasks as an early marker of functional 
decline in preclinical AD populations and explore potential links with cortical 
thickness as a proxy of brain structure. 84 participants including healthy controls 
(HC) (n=26), people with SCD (n=29) and patients with MCI (n=29) were tested 
using cognitive assessments including three event-based PM tests from the 
Rivermead Behavioural Memory Test-3 and the Nottingham Extended Activities of 
Daily Living Scale (NEADL). Most participants also underwent structural MRI to 
examine cortical thickness. Findings showed PM performance to be correlated with 
NEADL scores, suggesting a decline in PM reflects a decline in independent 
functioning. Furthermore, PM was found to be correlated with average whole brain 
cortical thickness. In group-based analyses, patients with MCI performed 
significantly worse than HC and SCD groups in all aspects of PM. These findings 
suggest that PM tasks could provide good insight into everyday functioning in 
individuals at risk of developing dementia. Thus, PM tasks could be implemented 
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1.1 Alzheimer’s Disease – The Early Diagnosis Problem 
 
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease characterised 
by cognitive and functional impairment accompanied by changes in behaviour 
(McKhann et al., 1984). The increasing prevalence of AD is currently viewed as a 
global healthcare crisis with an enormous cost to the UK economy (Prince et al., 
2014). The number of people living with AD is rapidly increasing, with more than 46 
million AD patients globally and this number is forecast to double every two decades 
(Prince et al., 2015). In line with the diagnostic criteria published by McKhann et al. 
(1984), to provide a definitive AD diagnosis, a post-mortem brain examination was 
required to confirm the presence of amyloid plaque accumulation and neurofibrillary 
tangles of hyperphosphorylated tau. Tau protein plays a role in promoting the 
stability of microtubules, which is critical for normal neuronal functioning (Köpke et 
al., 1993). The abnormal hyperphosphorylation of tau leads to the formation of 
intraneuronal tangles, leading to neurofibrillary degeneration, which is one of the 
hallmark characteristics of AD (Arriagada et al., 1992). The new guidelines 
determined by the National Institute of Aging and the Alzheimer’s Association (NIA-
AA) has led to the revision and update of the clinical diagnostic criteria. In 
accordance with these changes, the evidence of biomarkers is used to inform 
diagnostic formulations (McKhann et al., 2011). 
 
AD is seen as a disease spectrum where patients are thought to go through a long 
asymptomatic disease phase, undergoing vast neuropathological changes during 
this period, yet remaining cognitively “normal” (Dubois et al., 2010;Amieva et al., 
2008;Bertens et al., 2015). This preclinical disease stage precedes the symptomatic 
(prodromal) stage of AD, which involves progressive decline in cognition, followed by 
functional impairment and eventually “full-blown” dementia (Villemagne et al., 
2013;Wilson et al., 2011;Amieva et al., 2008). A study of community-dwelling 
individuals (N = 693) used an extensive neuropsychological test battery and 
revealed that early detection of cognitive changes in people at risk of developing 
dementia is possible (Saxton et al., 2004). The combination of diagnostic guidelines 
produced by the International Working Group and NIA-AA utilises the presence of 
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biomarkers to identify prodromal or preclinical stages of AD (Dubois et al., 
2007;Jessen et al., 2014;Dubois et al., 2014;McKhann et al., 2011). Hence, it is 
possible to diagnose prodromal stages of AD, known as Mild Cognitive Impairment 
(MCI) (Albert et al., 2011;McKhann et al., 2011). 
 
Despite a plethora of potential biomarkers, relatively few have made it into the 
clinical sphere due to expense, lack of validity and/or invasiveness. The mainstay of 
dementia diagnosis is still to use brief neuropsychological testing and structural 
imaging (usually Computerised Tomography scans) (Davis et al., 2013). There is a 
lack of tests with diagnostic accuracy that can predict patients with MCI who will 
progress onto developing AD dementia. Using ecologically valid tests of day-to-day 
function could allow us to identify and target an earlier disease stage reflecting the 
real impact of pathologies that will lead to dementia. One critical feature of 
biomarkers is that they identify the presence of pathology in the brain. Yet, it is 
known that brain pathology does not always lead to functional decline (Iacono et al., 
2009). Therefore, biochemical and structural tests need to run alongside behavioural 
tests to identify the earliest deterioration in day-to-day function. By doing so, we can 
identify patients in need of early treatment and track its effects.  Based on the 
evidence narrated above, one of the aims of this study is to investigate the 
relationship between an ecologically valid neuropsychological assessment tool and 
activities of daily living in people with preclinical AD or populations at-risk of 
developing AD. One potential method of identifying early changes in everyday 
functioning is thought to be through prospective memory performance, which will be 
described in the next section.  
 
 
1.2 Prospective Memory – Definition, Relevance and Importance 
 
Prospective Memory (PM) is defined as remembering when an action needs to be 
performed at the appropriate time. An example of PM would be remembering to buy 
a bottle of milk on the way back from work (event-based PM) or remembering to turn 
the hob off in 20 minutes time (time-based PM). In contrast to retrospective memory, 
which deals with remembering events that happened in the past, PM deals with 
actions to be undertaken in the future. Craik suggested PM depends more on 
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internal control mechanisms, relative to retrospective memory (Craik, 1983;Craik, 
1986). These cognitive mechanisms involve recollection through the reconstruction 
of events in memory, which is directed by either external cues, such as a prompt 
from the experimenter, or self-initiated (internal) cues (Craik, 1986).  
 
The complex process of PM has been categorised into four stages: (i) intention 
formation and encoding, (ii) retention of intention, (iii) intention initiation and (iv) 
execution of intended action (Kliegel et al., 2000). PM is suggested to be one of the 
most demanding cognitive processes due to being highly dependent on self-initiated 
retrieval, which is controlled by systems of the prefrontal cortex (Craik, 1986;Kliegel 
et al., 2000).  
 
PM can be divided into two types; event-based PM and time-based PM (Einstein et 
al., 1992). The former is triggered by an external prompt (i.e. an event), whereas the 
latter requires the participant to undertake an action at a specific time (Einstein and 
McDaniel, 1990;Einstein et al., 1995). Amongst the two types of PM, time-based PM 
is suggested to be more dependent on mechanisms of internal control such as self-
initiated time monitoring, with the assumption of no mnemonic or ‘memory aids’ 
being used (d'Ydewalle et al., 2001). Hence, due to the strong aspect of self-
initiation, time-based PM is deemed more susceptible to age-related deterioration 
(Maylor, 1995;Einstein et al., 1995). Furthermore, PM is divided into two principal 
components, which are the prospective component and the retrospective 
component. The prospective component is the ability to recognise the appropriate 
cue in which the action is to be performed, also called “cue identification”. The 
retrospective component is remembering what the action to be performed is, also 
called “intention retrieval” (McDaniel and Einstein, 1992).   
 
PM forms a crucial part of independent daily functioning and causes significant 
decrement in independence when impaired (Kliegel and Martin, 2010;Burgess et al., 
2000). Around 50-80% of all reported everyday memory problems consist of some 
form of PM impairment (Terry, 1988;Crovitz and Daniel, 1984). Furthermore, PM 
carries significant clinical relevance with multiple studies reporting high prevalence 
(around 40%) of patients visiting memory clinics with problems in PM (Fortin et al., 
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2002;Kliegel and Martin, 2010). One interesting further question is determining 
theoretically the similarities or differences between PM and retrospective memory 
(Kliegel and Martin, 2010). We know that delayed memory (i.e. retrospective 
memory) is one of the most widely used and sensitive tests for early AD (Locascio et 
al., 1995;Pasquier, 1999;Albert, 1996). The extent to which PM would tell us more 
about developing AD than tests of delayed memory is highly clinically relevant but is, 
as yet, relatively underexplored.   
 
Here, we sought to explore PM’s influence on activities of daily living and how PM is 
impaired in people destined to develop AD. The next section will focus on the 
specific PM impairment in AD and preclinical AD populations. 
 
 
1.3 PM in Alzheimer’s Disease and Mild Cognitive Impairment 
 
PM plays a fundamental role in independent living, and has a significant impact on 
quality of life when impaired (Burgess et al., 2000). Several studies reported 
evidence regarding the impairment of PM at very early stages of AD (Maylor et al., 
2002;Huppert and Beardsall, 1993;Huppert et al., 2000). One of the striking findings 
was that PM tests were found to be more sensitive to early stages of dementia 
compared to conventional tests of retrospective (delayed) memory (Huppert and 
Beardsall, 1993). Hence, suggesting tests of PM have the potential to act as an 
indicator of early decline in cognition. Another study by Jones et al. (2006) provided 
further evidence regarding PM impairment in preclinical AD, where patients exhibited 
deficits in both prospective and retrospective components of PM. Additionally, 
authors reported an independent contribution of PM performance in predicting 
progression to AD, more so than that of retrospective memory (Jones et al., 2006). 
Yet, PM tests are not routinely used in clinics for diagnostic purposes. Most of the 
recent dementia research has focused on finding new biomarkers for early diagnosis 
(e.g. see review by (Barber, 2010)), however, we also need a guide to functional 
changes.  
 
Recent research focused on extensively studying PM in preclinical or prodromal 
stages of AD (i.e. MCI). MCI lies within the cognitive spectrum that spans normal 
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healthy aging and AD dementia. Researchers defined MCI as a diagnostic entity in 
which an individual presents specific deficits in cognition (e.g. executive functions, 
declarative memory or visuospatial abilities) and performs below the norm in 
standard psychometric tests, yet their functional abilities remain intact (Petersen, 
2004). Many studies demonstrated that PM is impaired in MCI, specifically in 
amnestic type (Kazui et al., 2005). Patients with amnestic MCI are the ones with a 
specific deficit in declarative memory, whereas patients with other cognitive deficits 
are categorised as non-amnestic MCI (Petersen, 2004).  
 
PM impairment in patients with MCI is more prominent in time-based PM tasks, 
compared to event-based ones (Troyer and Murphy, 2007;Karantzoulis et al., 2009). 
Furthermore, Karantzoulis et al. (2009) suggested that PM deficiency in amnestic 
MCI could be due to impaired cue identification, which forms a crucial part of PM 
particularly in the “intention initiation” stage. The next step would be to explore 
whether such differences in cue-identification (i.e. prospective component of PM) is 
predictive of future cognitive decline. The results of such investigation could improve 
identifying the subset of patients within the MCI group that are destined to develop 
AD dementia. Hence, with early detection, we might be able to target the disease at 
a more critical stage where treatment opportunities are much higher (i.e. prior to 
significant brain atrophy). 
 
MCI has become a recognised and clinically used diagnostic criterion, with 
approximately 10% chance of developing AD per year (Mitchell and Shiri-Feshki, 
2009;Petersen, 2004). To be diagnosed with MCI, patients need to perform poorly on 
at least one cognitive test. However, we know that patients have symptoms even 
before they perform badly on standard tests. Hence, a great deal of attention is being 
paid to the new suggested category of a pre-MCI population called Subjective 
Cognitive Decline (SCD). SCD at the stage of normal cognition is associated with an 
increased risk of developing AD pathology and cognitive decline progressing to AD 
dementia (Glodzik-Sobanska et al., 2007;Reisberg et al., 2010;Wang et al., 
2013;Petersen et al., 2001). Despite not yet being clinically used, SCD is defined for 
research purposes and has about 5-10% chance of progressing to MCI, which can 
lead to developing AD (Fernandez-Blazquez et al., 2016). Most of the evidence 
regarding the link between SCD and AD comes from neuroimaging studies showing 
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a decrease in the volume of the hippocampus, entorhinal cortex, frontotemporal pole 
and corpus callosum in the SCD group (Saykin et al., 2006;van Norden et al., 
2008;Wang et al., 2006). Individuals with SCD do not differ from Healthy Controls 
(HC) in standard neuropsychological tests, however, they do differ in their PM 
performance, where SCD group performs worse than HCs in PM (Lee et al., 
2018;Hsu et al., 2015). However, large-scale investigations in this area are needed 
to corroborate the accuracy of PM tasks as an early indicator of MCI and incipient 
AD in at-risk populations (i.e. SCD). In addition to utilising behavioural markers of AD 
in diagnosis, there is also great value in using structural biomarkers such as 
neuroimaging. In the following section, I will evaluate the evidence from 
neuroimaging studies regarding the brain regions involved in PM.   
 
1.4 Brain regions involved in PM 
 
Understanding the neural correlates of PM and identifying the brain regions involved 
in its components could potentially help target future treatments. The importance of 
the functional integrity of prefrontal areas in successful PM performance has been 
previously reported (Shallice and Burgess, 1991). Furthermore, studies 
demonstrated that processes utilised in PM involve structures from a wide range of 
neural networks such as the rostral prefrontal cortex (rPFC), the hippocampal 
complex and the parietal cortex (Okuda et al., 1998;Burgess et al., 2001;Burgess et 
al., 2003).  
 
Neuroimaging methods (e.g. Positron Emission Tomography and functional 
Magnetic Resonance Imaging), show that the anterior prefrontal region, which forms 
a part of the Brodmann Area 10, is activated consistently with event-based PM tasks 
(Burgess et al., 2001;Reynolds et al., 2009). Successful PM performance also 
corresponds with activation in both the medial temporal lobe (Palmer and McDonald, 
2000;Burgess et al., 2002) and the parietal lobe (Reynolds et al., 2009;Burgess et 
al., 2001;Martin et al., 2007). Considering the complex cognitive demands of PM, 
such as strategical detection in cue identification (prospective component) or the 
retrieval of an intended action (retrospective memory) (Schmitter-Edgecombe et al., 
2009), it is no surprise that a range of brain areas are involved in its execution.  
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Temporal pole (TP) has been shown to be involved in a range of cognitive functions 
including, visual discrimination (Vandenberghe et al., 1995), mnemonic matching 
and learning (Roland et al., 1990) and semantic and episodic memory (Nakamura et 
al., 2001;Snowden et al., 2004). Considering the involvement of TP in cognition and 
processes similar to event-based PM (e.g. mnemonic matching/learning, episodic 
memory) and its proximity to regions involved in PM (e.g. hippocampal complex), it is 
likely to be a brain region involved in successful PM performance. Thus, a further 
aim of this study was to explore brain regions involved (i.e. rPFC and TP) in PM 
through the use of structural MRI.  
 
MRI data was collected in pursuit of exploring the neural correlates of PM. 
Based on previous research showing that specific brain regions are involved in PM 
performance, MRI data was collected in this study to further explore changes in PM 
performance in relation to changes in brain structure. To do this, cortical thickness 
measures were used as a proxy of brain structure, since reduction in cortical 
thickness has been shown to be a biomarker linked with progression to 
neurodegenerative diseases such as AD (Hartikainen et al., 2012). Cortical thickness 
was used instead of other structural metrics (e.g. surface area or volume) due to 
evidence showing cortical thickness values obtained from FreeSurfer to be the most 
sensitive to the potential changes found between AD dementia patients and controls 
(Clarkson et al., 2011) as well as its strong reproducibility (Han et al., 
2006;Wonderlick et al., 2009;Govindarajan et al., 2014). The reason behind using 
cortical thickness as opposed to grey matter volume is discussed in further detail in 
the following section.  
 
1.5 Cortical Thickness vs Grey Matter Volume  
 
In structural neuroimaging studies, there are different parameters available to use 
when addressing hypotheses. A variety of representations of the brain 
neuroanatomy can be derived using a range of automated tools such as FreeSurfer 
(Fischl et al., 2004) and SPM (Dahnke et al., 2013). Two of the most commonly 
reported results from neuroimaging studies are cortical thickness and grey matter 
volume. Cortical thickness is independently measured as the distance between the 
pial surface and white matter surface at different regions of the cortex (Fischl and 
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Dale, 2000), whereas grey matter volume is a function of surface area and cortical 
thickness (Panizzon et al., 2009). The average thickness of subcortical regions can 
be obtained from the FreeSurfer v6.0 pipeline (Fischl and Dale, 2000). 
 
Where possible, analysing cortical thickness measures is recommended over grey 
matter volumes. One of the reasons for this is that the borders of regions of interest 
(ROI) are defined variably by different atlases and such variations alter regional 
volumes drastically. However, cortical thickness is not as affected by these 
variations. Hence, measuring cortical thickness is more robust to changes in 
definitions of boundaries, allowing us to draw conclusions that are more comparable 
to studies using different atlases.  
 
The cortical thickness values obtained from FreeSurfer has been demonstrated to be 
robust and reproducible in previous studies (Han et al., 2006;Wonderlick et al., 
2009;Govindarajan et al., 2014). Therefore, in this study, Freesurfer was used as the 
chosen software to obtain cortical thickness values following cortical parcellation in 





This study has sought to achieve the following 3 aims: 
1. Investigate differences in PM performance between MCI, SCD and HC 
groups.  
 
2. Explore the neural underpinnings of PM performance using structural 
neuroimaging. 
 








1. Event-based PM scores will be lower in patients with MCI and individuals with 
SCD compared to HC and may herald functional decline in people destined to 
develop dementia.  
 
2. The thickness of the rPFC and TP are expected to be positively correlated 
with PM performance. 
 
3. PM performance reflects day-to-day functional ability as manifest through 
scores in Nottingham Extended Activity of Daily Living questionnaire.  
 
 
1.8 Author’s contribution to this study 
 
This study was performed as a part of a larger-scale study of a PhD student (Alfie 
Wearn). Due to the September start date of my MSc (by research) degree, I was not 
able to take part in the design of the study since the project had already started in 
May 2017. From September 2017, I undertook the majority of recruitment and data 
collection. In terms of data analysis, I undertook the analysis of neuropsychological 
data mostly independently and with some guidance from my supervisor Liz 
Coulthard. The neuroimaging data analysis was undertaken in collaboration with the 
PhD student, Alfie Wearn, since the output from the analysis of this data formed a 
part of both studies. During data analysis, I also used scripts written by a former 
research team member, Dr Michael Knight, for data manipulation procedures. Due to 
the metrics specifically needed for my study, I played a major role in FreeSurfer 













Participants were recruited from a variety of registered databases of patients and 
healthy elderly people who are willing to take part in research. The majority of HCs 
were recruited from the Join Dementia Research database given they met the 
inclusion criteria. Participants with SCD were recruited from various sources 
including local GPs, Join Dementia Research and the Memory Clinic at the North 
Bristol NHS Trust. Patients with a diagnosis of MCI were also recruited from the 
Memory Clinic at the North Bristol NHS Trust, local GPs as well as the Avon and 
Wiltshire Mental Health Partnership NHS Trust’s Everyone Included database.  
 
Inclusion criteria: People with a diagnosis of MCI, age-matched individuals with SCD 
(defined as a self-perception of memory problems but normal performance on 
clinically used memory tests (e.g. ACE-III)) and age-matched HCs. 
 
Exclusion criteria: Any significant neurological disorder that might affect test 
performance, History of neurosurgery, diagnosis of AD dementia or any other form of 
dementia. 
 
This study is reviewed and approved by the NHS Frenchay Research Ethics 
Committee. Participants provided written consent to take part in this study prior to 
any form of testing.  
 
2.1.2 Participant Classification  
 
Participants were classified into the following 3 groups; HC, SCD and MCI 
depending on the criteria shown in Figure 1. Participants were nominated to be 
placed in the SCD group if they responded ‘Yes’ to 2 or more of the questions shown 
in Table 1. Subsequently, if they scored 88 or higher in the Addenbrooke’s Cognitive 
Examination - III (ACE-III) (Crawford et al., 2012), had a Clinical Dementia Rating 
(CDR) score of 0 (Morris, 1993) and scored 121 or higher in the Rivermead 
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Behavioural Memory Test - 3 (RBMT-3), they were placed in the SCD group. 
Patients with a diagnosis of MCI were placed in the aMCI group. Additionally, 
patients with a self-report of SCD were placed in the MCI group, if they had an ACE-
III score below 88 and/or an RBMT-3 score below. Lastly, if participants had an ACE-
III score of 88 and above, a CDR score of 0.5 or under and an RBMT-3 score of 97.5 
or higher, they were placed in the HC group.  
 
 
Figure 1: Classification criteria used to determine participant groups.  
The RBMT-3 classification criteria was calculated as Mean scaled score -1 Standard 
Deviation (SD) for the SCD group and -2 SD for the HC group (Wilson et al., 2008).  
 
Questions  Yes / No 
Are you concerned about your memory? Y/N 
Do you think that your memory is worse than 5 years ago? Y/N 




Table 1: Classification criteria used to determine whether participants will be placed 













ACE ≥ 88 ACE ≥ 88
Y N
CDR ≤ 0.5 
RBMT ≥ 97.5
CDR = 0 MCI




*Can have CDR 0.5, “benign 
forgetfulness” and still be 
unconcerned about memory 
loss, therefore, still healthy 
control. I.e. “memory is not 
what it used to be but I’m not 
worried about it and I don’t 
think it’s worse than it should 
be for my age”
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2.2 Materials 
2.2.1 Cognitive and Neuropsychological tests 
 
Clinical Dementia Rating Scale (CDR) is a tool to measure global dementia severity 
using collective information regarding Memory, Home & Hobbies, Personal Care, 
Community Affairs and Orientation obtained from the participant and the informant. A 
5-point scale is used to evaluate the participants functioning in each category. The 5-
point scale is as follows: Normal (0), Questionable/Very mild dementia (0.5), Mild 
Dementia (1), Moderate Dementia (2) and Severe Dementia (3).  
The CDR scoring algorithm was used to obtain the overall CDR score of each 
participant (Morris, 1993).   
 
Rivermead Behavioural Memory Tests – Third Edition (RBMT-3) (Wilson et al., 1989) 
is a battery of ecological memory tests that provides information about a subject’s 
memory performance in their daily life.  
 
The RBMT-3 consists of the following subtests:  
 
1. First and Second Names: remembering the first and second names of two 
people. Scoring was performed as follows: 
Each first name remembered spontaneously: 2, after a prompt: 1. Each 
second name remembered spontaneously: 2, after a prompt: 1. Maximum raw 
scores: 4 for first names and 4 for second names. 
 
2. Picture Recognition: recognising 15 pictures that were previously presented 
and distinguishing them from a range of distractor pictures. Scoring was 
performed as follows: 
A score of 1 is given for each correctly recognised picture and a score of 1 is 
deducted from each incorrect recognition (false positives). Max raw score: 15. 
 
3. Appointments: remembering to ask two questions after the alarm rings. 
Scoring was performed as follows: 
 20 
Each spontaneously asked question: 2, after a prompt: 1. Remembering two 
things had to be done but not remembering what they were: 2. Remembering 
one thing had to be done but not remembering what it was: 1. Maximum raw 
score: 4.  
 
4. Story (immediate and delayed recall): immediate and delayed recall of a short 
story. Scoring was performed as follows: 
Each perfect or close synonym recall of an idea: 1, partial or approximate 
synonym used for each idea: ½. If the participant required a prompt a score of 
1 is deducted. If a prompt is used, the first two ideas are not credited. 
Maximum raw scores: immediate recall 21, delayed recall 21.  
 
5. Route (immediate and delayed recall): immediate and delayed retracing of a 
6-point route shown by the examiner. Scoring was performed as follows: 
Each correct location visited: 1. A score of 1 was given to each of the correct 
starting point and finishing point. Finally, each point was considered with the 
next location following it. The correct recall of a pair of points was given a 
score of 1. Maximum raw scores: immediate recall 13, delayed recall 13.  
 
6. Messages (immediate and delayed recall): immediate and delayed 
remembering to pick up a message and a book and deliver them to the 
correct location during the recall of the Route. Scoring was performed as 
follows: 
Spontaneously picking up the ‘Message’: 2, after a prompt: 1. Spontaneously 
picking up the book: 2, after a prompt: 1. Leaving the message at the correct 
location: 1. Leaving the book at the correct location: 1. Maximum raw scores: 
immediate 6, delayed: 6.  
 
7. Face Recognition: recognising 15 faces that were previously presented and 
distinguishing them from a range of distractor images. Scoring was performed 
as follows: 
Each correctly recognised face: 1. A score of 1 was deducted for each 
incorrectly recognised face (false positive). Maximum raw score: 15.  
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8. Novel Task (immediate and delayed recall): remembering how to form a 
shape (either a star or a square) using the coloured pieces provided as well 
as remembering the order in which each piece is placed in the template. In 
the immediate recall stage, the task is repeated 3 times. In each trial the 
examiner demonstrates how to place the pieces to form the shape (star or 
square), using a specific order. In the recall stage, the participant is asked to 
form the shape once more with no demonstration from the examiner. Scoring 
was performed as follows:  
For each trial; a score of 1 was given to each correctly positioned piece, a 
score of 1 was given to each correct order. Then, each piece was considered 
in turn with the piece following it and a score of 1 was given to each correctly 
recalled pair order. Maximum raw score for each trial: 17. Maximum raw score 
for immediate recall: 51. Maximum raw score for delayed recall: 17.  
 
9. Date and Orientation: answering 13 questions regarding the date and 
orientation to time, place and person. Scoring was performed as follows: 
Questions 1-3, 6-9 – A score of 1 was given to each correct answer.  
Question 4 – A score of 1 was given if the answer was within half an hour of 
the correct time.   
Questions 10-13 – A score of 1 was given if the correct first name and second 
name was given. A score of ½ was given for the correct surname only.  
Maximum raw score: 14.  
 
10. Belongings: remembering where two of their belongings are hidden. Scoring 
was performed as follows: 
Each item recalled spontaneously: 2, after a prompt:1. Each location recalled 
spontaneously: 2, after a prompt: 1. Maximum raw score: 8. 
 
Furthermore, the RBMT-3 battery offers 2 different versions that can be used in 
intervention studies and the assessment of follow-ups (Wills et al., 2000). Both 
versions were equally implemented in this study, in a randomised manner.  
Activities of Daily Living Questionnaire (ADLQ) is an assessment of everyday 
functionality based on information provided by an informant (someone who knows 
the subject’s daily activities and functioning) (Johnson et al., 2004). The ADLQ scale 
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consists of six sections covering various areas of functioning (Self-care, Household, 
Employment, Shopping, Travel, Communication). Each section is composed of three 
to six items and scored on a 4-point scale. A score of 0 (no problem) to 3 (can no 
longer undertake this activity) is given to each item. If the respondent chooses 9 
(never done this activity/stopped before onset of dementia-related problems/don’t 
know) as the answer, that question is not included when calculating the score for that 
specific subsection. The answers were scored as follows: 
 
The formula illustrated below was used to calculate the total score, ranging from 0 to 
100 (Figure 2). The score representing the highest level of impairment is used as 
the denominator (i.e. if all items were rated a score of 3), excluding the items marked 
“9”. The total of ratings chosen by the respondent is represented by the numerator, 
excluding the items marked “9”. Resultantly, the score obtained from the formula 
denotes the severity of impairment in daily functioning. Subsequently, the level of 
functional impairment is ranked as follows: 
 
“None to mild” for a score of 0-33%, “Moderate” for a score of 34-66%, “Severe” for a 
score greater than 66%. The score of functional impairment is calculated for the total 
of all items as well as for each individual subscale. 
 
 
𝐹𝑢𝑛𝑐𝑡𝑖𝑜𝑛𝑎𝑙 𝐼𝑚𝑝𝑎𝑖𝑟𝑚𝑒𝑛𝑡 =  
𝑆𝑢𝑚 𝑜𝑓 𝑎𝑙𝑙 𝑟𝑎𝑡𝑖𝑛𝑔𝑠
3 ×  𝑡𝑜𝑡𝑎𝑙 𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑡𝑒𝑚𝑠 𝑟𝑎𝑡𝑒𝑑




Figure 2: The formula used to calculate the functional impairment score (%) 






Addenbrooke’s Cognitive Examination (ACE-III) is one of the most commonly used 
clinical screening tools for the assessment of cognition in the UK (Newman et al., 
2018). The ACE-III is used to detect and distinguish between different types of 
dementia (e.g. Alzheimer’s Disease and Frontotemporal Dementia) (Hsieh et al., 
2013). The 24 items in the test contribute to the assessment of five subdomains of 
cognition: memory (26 points), attention (18 points), language (26 points), 
visuospatial functioning (16 points) and fluency (14 points). The scores from all five 
subdomains make up the final ACE-III score out of a total of 100.  
 
 
Brief Cognitive Rating Scale (BCRS) is utilised in the assessment of cognitive 
abilities and functionality in healthy aging as well as progressive dementia (Reisberg 
and Ferris, 1988). Five domains of cognition and functional abilities (Concentration, 
Recent Memory, Past Memory, Orientation and Functioning and Self Care) were 
assessed using BCRS. Each domain is rated on a 7-point scale ranging from 1 
(normal) to 7 (severe impairment). 
 
Nottingham Extended Activities of Daily Living Scale (NEADL) is used to measure 
independence in instrumental activities of daily living (Nicholl et al., 2002). The 22-
item scale is scored on the basis of the frequency of performing each activity. The 
overall NEADL score is a collection of scores obtained from four generic categories 
of daily living: Mobility (Q1-6), Kitchen (Q7-11), Domestic (Q12-16) and Leisure 
(Q17-22). A score of 0 was given if the participant has chosen “never” or “with help”. 
A score of 1 was given if the participant has chosen “on my own with difficulty” or “on 
my own”. The maximum score is 22, where a higher score represents a higher level 
of independence in day-to-day functioning.  
 
Depression, Anxiety and Stress Scale 21 (DASS 21) is a set of 3 short, self-reported 
questionnaires that measure levels of depression, anxiety and stress (Henry and 
Crawford, 2005). This questionnaire assesses the frequency of experiencing 21 
symptoms over the past week and is scored on a 4-point scale in the hierarchy of 0 
(never), 1 (sometimes), 2 (often) and 3 (almost always). The final scores are 
multiplied by 2 and categorised as shown in Table 2. 
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Severity Depression Anxiety Stress 
Normal 0-9 0-7 0-14 
Mild  10-13 8-9 15-18 
Moderate 14-20 10-14 19-25 
Severe 21-27 15-19 26-33 
Extremely Severe 28+ 20+ 34+ 
 
Table 2: Score ranges used for the categorization of participants on DASS 21 
(Henry and Crawford, 2005). 
 
California Verbal Learning Test – Second Edition (CVLT-II) is a widely used 
neuropsychological test episodic verbal learning and memory, which includes a 16-
item word list with words belonging to four categories (e.g. animals, clothing, tools 
and fruits) (Woods et al., 2006). The trials range from 1 to 5 repeats in the learning 
phase, where participants need to be able to recall 75% (12 words) of the list. Then a 
second, distractor list is read to participant once and the recalled words are 
recorded. The following stages of the test are short-delay free recall, short-delay 
cued recall, long-term free recall, long-term cued recall and recognition. At each 
stage, the answers are scored as either correct, repetition or intrusion.  
 
Paired Associates Learning Task (PAL) is a neuropsychological assessment of 
visuospatial memory and learning. PAL has been shown to be a particularly good for 
predicting further cognitive decline, thus it has strong predictive validity for the 
development of AD (Fowler et al., 2002). A touch-sensitive, flat-screen display 
monitor has been used to administer this task. PAL focuses on participant’s ability to 
associate visual patterns (that are difficult to verbalise) with spatial locations on the 
display monitor (Barnett et al., 2005). PAL assesses the ability to remember patterns 
in association with their location on the display. In this task, six white boxes, that are 
evenly spaced on the display, start to randomly disappear one by one for 3 seconds 
each. At the first level, there is only one box containing a pattern. Once all boxes 
have disappeared and came back, the pattern appears in the centre, and the 
participant is asked to touch the box this pattern was present earlier. Upon 
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successful completion of the level, the task moves on to the next level with more 
patterns to remember. If the participants fail to remember where the patterns were, 
the task automatically repeats itself with a maximum of 6 trials. The task starts with 
two levels with a single pattern, then proceeds to two levels with two patterns, 
followed by two levels with three patterns and then to a level with six patterns, and 
ultimately to a level with eight patterns. The outcome measures obtained from the 
test consist of trials to criterion, errors to criterion and maximum level completed.  
 
Rey-Osterrieth Complex Figure Test (ROCFT) is a neuropsychological test used to 
assess visuospatial ability and memory as well as executive function mediated by 
the prefrontal lobe (Shin et al., 2006). This task begins with a copy condition where 
the participant makes a copy of the figure by looking at it. Following this, the 
participant is asked to draw a copy of the figure from memory in the absence of the 
original figure, known as the Immediate Recall condition. These 2 steps are repeated 
for up to a maximum of 5 times until the participant can recall 75% of the figure. 
Then, there is a Delayed Recall stage (20-30 minutes later), where the participant is 
asked to draw a copy of the figure from memory on a blank response sheet. Lastly, 
there is a Recognition stage, where the participant is asked to select the shapes that 
have made a part of the complex figure from a collection of correct and incorrect 
shapes. The Quantitative Scoring System (detailed in (Shin et al., 2006)) was utilised 
in scoring the performance on the ROCFT. The scoring of ROCFT was performed as 
follows: 
 
A score of 2 was given for each accurately drawn and correctly placed piece 
of the figure. A score of 1 was given if the piece was accurately drawn but 
incorrectly placed. Alternatively, a score of 1 was given if the piece was 
correctly placed but inaccurately drawn. A score of 0.5 was given to pieced 
that was inaccurately drawn and incorrectly placed, yet, were recognizable. A 
score of 0 was given to each piece that was inaccurately drawn and 






Prospective Memory test administration 
In this study, the PM sub-tests from the RBMT-3 battery have been used to assess 






Participants’ performance on the 3 subtests have been assessed in 2 components of 
PM: “cue-identification” (prospective component) and “intention retrieval” 
(retrospective component). The scoring of each subtest was performed as follows: 
 
1. Belongings: A score of 1 was given for the “cue-identification” component if an 
item or location was spontaneously remembered. Maximum raw score for 
“cue-identification”: 4. A score of 1 was given for the “intention retrieval” 
component for remember each item or location either spontaneously or after a 
prompt. Maximum raw score for “intention retrieval”: 4.  
 
2. Appointments: A score of 1 was given for the “cue-identification” component if 
a question was spontaneously asked or for remembering something had to be 
done. Maximum raw score: 2. A score of 1 was given for the “intention 
retrieval” component for remembering each question accurately. Maximum 
raw score: 2.  
 
3. Messages (immediate and delayed recall): A score of 1 was given for the 
“cue-identification” component if the message or the book was spontaneously 
picked up. Maximum raw score: 2. A score of 1 was given for picking up each 
of the correct items and placing each of them in the correct location. 
Maximum raw score: 4.  
 
The total PM raw score was calculated as the sum of the raw scores from each 
subtest. The total PM score was then converted into a percentage by dividing the 
total PM raw score by the total maximum PM raw score (24) and then multiplying the 
result by 100.  
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2.2.2 Magnetic Resonance Imaging procedures 
 
Image Acquisition 
All magnetic resonance imaging (MRI) was undertaken using a Siemens Magnetom 
Skyra 3T system. The system was also equipped with a 32-channel head receiver 
array coil and a parallel transmit body coil. The imaging protocol used for the results 
presented in this thesis was adapted from (Knight et al., 2016) and was as follows:  
 
3D T1-weighted Magnetisation-Prepared Rapid Gradient Echo (MPRAGE) with the 
parameters: sagittal, TR 2200 ms, TE 2.28 ms, TI 900 ms, flip angle 9°, FOV 220 x 
220 x 179 mm, acquired resolution 0.86x0.86x0.86 mm3, acquired matrix size 256 x 
256 x 208, acquisition time 5 minutes and 7 seconds. 
 
The rest of the protocol included 2D high-resolution hippocampal turbo spin-echo 
(one multi-contrast, one single contrast) with the parameters (acquisition times 5 
minutes and 9 seconds and 3 minutes and 17 seconds, respectively), 2D multi-
contrast spin-echo (acquisition time 7 minutes and 9 seconds) and 2D Diffusion 
Tensor Imaging (acquisition time 3 minutes and 15 seconds).   
 
 
Image Processing and Cortical Thickness Estimation  
Cortical parcellation was performed according to the Destrieux atlas of FreeSurfer 
version 6.0 (Fischl et al., 2004). 3D T1-weighted MPRAGE images were used in the 
surface-based cortical parcellation process (Figure 3). The methods for cortical 
parcellation using FreeSurfer have been described in detail in other studies (Dale et 
al., 1999;Fischl and Dale, 2000;Rosas et al., 2002;Salat et al., 2004;Fischl et al., 
2004).  
 
In brief, the automated cortical parcellation procedure includes processes such as 
normalisation of intensity, skull stripping, cerebral white matter segmentation as well 
as the estimation of the grey/white matter boundary (Dale et al., 1999). Following 
topological defect corrections, the grey/white matter boundary is used to locate the 
pial surface and cortical thickness was then measured (Fischl and Dale, 2000). This 
method has been validated (Rosas et al., 2002) and it has been shown to be reliable 
(Han et al., 2006;Dickerson et al., 2008).  
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The following regions were used in data analysis: 
G&S_transv_frontopol region was used to determine rPFC cortical thickness values.  
Pole_temporal region was used to determine the TP cortical thickness values.  
Pole_occipital region was used to determine Occipital Pole (OP) cortical thickness 





Figure 3: Pial surface representation of the automated cortical parcellation 
procedure carried out using FreeSurfer version 6.0 (Fischl et al., 2004). Colours 











2.2.3 Statistical Analyses 
 
All statistical analyses were performed using IBM SPSS version 24. GraphPad Prism 
version 7, IBM SPSS version 24 and Microsoft Office software (Excel and 
PowerPoint) were used for visualisation of results in various forms (e.g. graphs, 
tables). All demographic data was explored, and normality was checked through the 
Descriptive Statistics function of SPSS. A Pearson’s chi-squared test was run to 
check for gender balance within groups. A univariate analysis of variance (ANOVA) 
was performed to check whether there was an age difference between groups. Since 
the data violated assumptions of normality and age was identified as a covariate, the 
non-parametric analysis of covariance test, Quade’s test, was performed with post 
hoc pairwise comparisons to compare PM performance across groups. Since the 
data did not meet the assumptions of normality and age was a covariate, the partial 
correlation test was run to investigate the relationship between PM performance and 
NEADL. The same correlation analysis was run on PM performance and average 
thickness of rPFC and TP. In these correlation analyses the whole participant 
population was combined and compared against the dependent variable (i.e. ROI 
cortical thickness or NEADL scores). Group-based correlations were not carried out, 
due to the lack of statistical power of individual groups as a result of small sample 
sizes.  
 
In all analyses, p < 0.05 was accepted as statistically significant. In instances where 
multiple comparisons were undertaken, a Bonferroni correction for multiple tests was 
used. Left and right hemispheres were averaged to calculate average cortical 
thickness in each brain region. This was done to account for differences in 
hemispheres between individuals, since there were both right and left-handed 









3.1 Demographic characteristics of the participant sample 
  
The demographics of the sample together with the average performance on the tests 
used in this study are presented in Table 3.  
 
 






61 - 89 
71.10 ±8.14 
 
55 - 86 
78.59 ±9.16 
 
53 - 94 
0.068 
Gender (male) 46.15% 58.62% 68.96% 0.230 
Years of Education 
(years) 
15.92 ±4.08 15.58 ±3.55 13.71 ±3.16 0.054 
IQ  108.91 ±11.08 107.68 ±9.14 104.00 ±9.14 0.101 
Performance on Neuropsychological Tests used in classification 
ACE-III 95.55 ±2.37 93.85 ±3.73 79.47±8.37 0.856 
RBMT-3 162.25 ±16.87 149.43 ±21.51 91.77 ±26.47 0.988 
 
Table 3: Summary of the demographic data of all 3 participant groups. (RBMT-3 
scores represent raw scores) (Results across groups represent Mean ±SD, except 
















3.2 The effect of Age 
 
The effect of age on PM performance:  
A spearman’s rank-order correlation test revealed that age is neatively correlated 
with PM performance (N = 84, rs = 0.451, p < 0.001). Subsequent to this finding, a 
parametric one-way ANOVA was run to check whether the distribution of age was 
the same across groups. The results of this analysis demonstrated that there was no 
difference in age between groups (p = 0.068). 
 
The effect of age on ROI thickness:  
A spearman’s rank-order correlation test showed age was not significantly correlated 
with either average rPFC or TP thickness (N = 62, rs = 0.156, p = 0.225 and rs = 
0.092, p = 0.480, respectively).   
 
Since age was only correlated with PM scores, it was controlled as a covariate in all 




















3.3 PM Performance across Groups 
 
Event-based PM performance was compared across 3 groups; HC (N = 26), SCD (N 






















Figure 4: The performance of the 3 
groups in prospective memory tasks 
presented as total PM score (%) as 
well as prospective component and 
retrospective component (*** = p < 
0.001) (N = 84).  






Total Prospective Memory: A significant difference of means across groups was 
found (Quade’s F (2,81) = 39.14, p < 0.001) (shown in A of Figure 4). Following this, 
post hoc tests with Bonferroni corrections were conducted to test pairwise 
comparisons. The MCI group (M = 48.34, SD = 19.89) was significantly different from 
HC (M = 86.45, SD = 7.32) (p < 0.001) and SCD (M = 80.66, SD = 9.70) (p < 0.001). 
However, there was no significant difference between the HC and SCD groups (p = 
0.078). 
 
Prospective Component: A significant difference of means across groups was found 
(Quade’s F (2,81) = 33.98, p < 0.001) (shown in B of Figure 4). Following this, post 
hoc tests with Bonferroni corrections were conducted to test pairwise comparisons. 
The group (M = 34.12, SD = 18.39) was significantly different from HC (M = 81.00, 
SD = 14.47) (p < 0.001) and SCD (M = 73.00, SD = 13.80) (p < 0.001). However, 
there was no significant difference between the HC and SCD groups (p = 0.180). 
 
Retrospective Component: A significant difference of means across groups was 
found (Quade’s F (2,81) = 21.40, p < 0.001) (shown in C of Figure 4). Following this, 
post hoc tests with Bonferroni corrections were conducted to test pairwise 
comparisons. The MCI group (M = 61.13, SD = 26.45) was significantly different from 
HC (M = 91.96, SD = 8.62) (p < 0.001) and SCD (M = 87.86, SD = 11.03) (p < 
0.001). However, there was no significant difference between the HC and SCD 














3.3 The relationship between PM and Cortical Thickness 
 








2.53 ±0.15 2.49 ±0.30 2.37 ±0.01 0.009 
HC-MCI = 0.007 
SCD-MCI = 0.090 
HC-SCD = 0.664 
Average TP 
thickness 









2.49 ±0.11 2.44 ±0.07 2.35 ±0.09 0.009 
HC-MCI = 0.008 
SCD-MCI = 0.413 
HC-SCD = 0.149 
 
Table 4: The cortical thickness values (mm) of 3 brain regions (2 ROIs and 1 
Control) and the whole brain. (Results across groups represent Mean ±SD).  
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Figure 5: The scatter plots illustrate the relationship between PM performance and 
the thickness of a) Rostral Prefrontal Cortex (rPFC), b) Temporal Pole (TP), c) 
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The average thickness of each brain region across groups as well as the whole brain 
is illustrated in Table 4 in the form of Mean ± SD. 
 
A partial correlation was performed to investigate the relationship between PM 
performance and a) rPFC and b) TP, whilst controlling for age, as illustrated in 
Figure 5. The results showed that PM performance and the average thickness of 
rPFC were positively correlated with high statistical significance (N = 62, r = 0.439, p 
< 0.001). Furthermore, there was also a strong positive correlation, which was 
statistically significant, between PM performance and the average thickness of TP (N 
= 62, r = 0.344, p = 0.007).  
 
The total PM performance was found to be correlated with the thickness of the 
control region (c) OP in Figure 5) (N = 62, r = 0.263, p = 0.041). However, when 
investigating the relationship between OP thickness and the prospective component 
on PM, there was no significant correlation found (r = 0.222, p = 0.086). Yet, there 
was a positive correlation between prospective component of PM and both rPFC and 
TP thicknesses which was highly significant (r = 0.432, p < 0.001 and r = 0.365, p = 
0.004, respectively). The retrospective component of PM had the higher correlation 
with rPFC (r = 0.778, p = 0.001) compared to OP (rs = 0.344, p = 0.007). There was 
no significant correlation between the retrospective component of PM and the TP (r 
= 0.202, p = 0.118). 
 
Following results shown above, a posthoc analysis of whole brain cortical thickness 
and PM performance has been conducted to investigate whether PM performance is 
correlated with cortical thickness of the whole brain. A partial correlation analysis of 
the relationship between average whole brain cortical thickness and PM 
performance, whilst controlling for age, showed a moderate and significant 








3.5 The relationship between PM and Activities of Daily Living 
 
A partial correlation analysis was performed to investigate the relationship between 
total PM score and the NEADL score. The results showed that there was a strong 
positive correlation between PM performance and the NEADL score with high 
statistical significance, whilst controlling for age (N = 71, r = 0.255, p = 0.033). 
Furthermore, the relationship between the two components of PM (i.e. prospective 
component and retrospective component) with NEADL was also investigated in the 
same manner. The outcome of this analysis showed that the prospective component 
was not significantly correlated with NEADL (N = 71, r = 0.201, p = 0.095). The 






4.1 Differences in PM performance across Groups 
 
The results shown in Figure 4 demonstrate that the MCI group performance in 
event-based PM tasks was significantly worse than the HC and SCD groups, 
partially supporting Hypothesis 1. However, no significant difference in the 
performance of the HC and the SCD groups was observed in the event-based PM 
tasks. Hence for the second half of Hypothesis 1, the null hypothesis is accepted.  
 
As demonstrated in this study, the MCI group had an impairment in evet-based PM, 
supporting previous findings (Kazui et al., 2005;Troyer and Murphy, 
2007;Karantzoulis et al., 2009;Bolló-Gasol et al., 2014). Yet, no difference between 
the SCD and HC groups was observed, contrary to the hypothesis. This suggests 
that the SCD group may not differ from the HC group in event-based PM tasks, 
despite previously being reported to differ in time-based PM tasks (Hsu et al., 2015). 
However, it is difficult to make concrete statements regarding the difference in event-
based PM between the SCD and HC groups since this has not yet been extensively 
studied. One of the reasons that there was no difference observed could be due to 
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the nature of the lab-based tests not being able to detect such subtle changes in PM 
performance in pre-MCI groups (i.e. SCD). A recent study by Lee et al. (2018), 
demonstrated that a difference between the SCD and HC groups in PM was 
detected when they used more naturalistic tasks of PM with stronger resemblance of 
real life day-to-day functioning (e.g. The Supermarket Shopping Trip Task (Kinsella 
et al., 2009)). Thus, further research is needed to investigate whether there is a 




4.2 PM performance and Cortical Thickness 
 
In accordance with the results reported above and illustrated in Figure 5, the null 
hypothesis that there is no positive correlation between the average thickness of the 
ROIs (i.e. rPFC and TP) and PM performance is rejected. Although Hypothesis 2 
was confirmed, there was also a significant correlation between PM performance 
and the control region, OP, which is thought to be unrelated to PM. Hence, in this 
instance, it is not possible to make direct inferences regarding a potential 
relationship between the cortical thinning of specific brain areas (i.e. rPFC and TP) 
and PM impairment. In addition, it is very difficult to make statements about a causal 
relationship between two parameters (e.g. Cortical Thickness and PM performance) 
from a cross sectional study such as this. In future experiments, a longitudinal 
experimental design such as studying a group of individuals over a period of 10 
years whereby neuropsychological assessment and neuroimaging is undertaken at 
regular intervals (e.g. every 6 months) could be a better way of investigating a causal 
relationship. Alternatively, use of different methodology such as functional MRI would 
allow exploring the relationship between blood oxygen-level dependent signals from 
specific brain regions and PM performance. A further alternative method could be 
the use of transcranial magnetic stimulation on specific brain regions to study the 
direct relationship between the activation/stimulation of a specific brain region and its 
influence on function (e.g. PM performance).  
 
Furthermore, it is important to note that the MCI population is highly heterogeneous 
where only a part of the patient population will develop AD pathology and the rest will 
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have other disorders or recover (Libon et al., 2010;Delano-Wood et al., 
2009;Koepsell and Monsell, 2012). Even the part of the MCI group that will develop 
AD pathology might have a range of comorbidities rather than solely AD (Grande et 
al., 2016;Tsolaki et al., 2016). Hence, studying the effects of specific brain regions 
on a memory type in a heterogeneous group, such as MCI, is highly challenging. To 
truly explore the effects of a brain region on a memory type, the aforementioned 
future experiments can be implemented (e.g. use of transcranial magnetic 
stimulation).   
 
One of the interesting outcomes of this study was that PM is correlated with general 
cortical thinning. This is supported by the finding that there was a significant 
correlation between PM and the OP, a brain region thought to be insignificant to PM 
performance. Hence, based on the evidence from this study, it is thought that PM 
performance is correlated with general cortical thinning as opposed to cortical 
thinning of specific brain regions in preclinical AD groups. As mentioned above, there 
could be a range of reasons why there was no significant correlation between PM 
performance and specific brain regions. One reason could be that the majority of the 
patient population had MCI that would revert to normal cognition or had MCI due to 
other neurological conditions than AD. Furthermore, using structural MRI might not 
be sensitive enough at preclinical stages of AD to study the relationship between 
specific brain regions and cognitive/memory subdomains/subtypes. It could be 
argued that functional MRI or positron emission tomography might be better tools to 
study direct activation of specific brain regions in preclinical AD populations during 
event-based PM tasks. Nevertheless, this finding supports the use of event-based 
PM tests in memory clinics as a guide to early functional decline in incipient AD.  
 
The cortical thickness of rPFC had the strongest correlation with PM, as well as its 
prospective and retrospective components compared to the other 2 brain regions 
(TP and OP) investigated in this study. This finding is in line with Burgess et al. 
(2003), supporting the importance of rPFC in successful PM performance. Moreover, 
the TP was also found to be highly correlated with only the prospective component of 
PM, suggesting TP might play an important role in the cue-identification phase of 
PM.    
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4.3 PM performance and Activities of Daily Living 
 
Both components of PM have been found to be correlated with functional 
independence in daily life (as measured by NEADL scores) in accordance with 
Burgess et al. (2000). Furthermore, the retrospective component was found to have 
a greater impact on functional independence than the prospective component. This 
suggests that the retrospective component could compensate for the impairment in 
the prospective component in day-to-day activities. Thus, when the retrospective 
component is also impaired, a greater impact on day-to-day functioning and the 
independence of patients could be expected. 
  
Due the its high functional relevance, problems in PM have been found to be one of 
the most commonly reported early signs of AD (Smith et al., 2000). In addition to 
this, carers reported that PM failures were even more burdensome than 
retrospective memory impairment, supporting the importance of PM in everyday 
functioning (Smith et al., 2000). Hence, providing further evidence for the value of 
PM tasks as a guide to early functional decline in preclinical AD. 
 
 
 4.4 Methodology for cortical thickness measurement and event-based PM 
 
FreeSurfer was chosen to perform the automated cortical parcellation in this study. 
This software was selected because of its high reliability for cortical thickness 
measurement (Han et al., 2006). 3D T1-weighted MPRAGE images were used in the 
cortical parcellation process to obtain average cortical thickness of ROIs, which has 
been shown to be accurate, especially compared to other scan types (e.g. 2D spin-
echo images) (Vidal-Jordana et al., 2017).  
 
RBMT-3 was the selected cognitive test battery due to its high ecological validity and 
the variety of tests included to assess multiple domains of cognition. RBMT has been 
found to correlate with conventional tests of episodic memory (e.g. the Weschler 
Memory Scale and CAMCOG), commonly used for diagnostic purposes (Makatura et 
al., 1999;Perez and Godoy, 1998;Yassuda et al., 2010). Additionally, RBMT-3 is able 
to differentiate between HC, MCI and AD groups (Yassuda et al., 2010;Kazui et al., 
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2005). As the event-based PM tasks were a subset of RBMT-3, our results are 
strengthened by the good reliability of the test battery (Küçükdeveci et al., 2009). 
 
However, the total RBMT-3 scaled score was used as a final stage classifier to 
categorise individuals into groups, following CDR and ACE-III scores. Therefore, one 
could argue that the between group differences found in PM performance could be 
due to the event-based PM tasks being a subtest of RBMT-3, originally used as a 
factor in participant classification. Yet, the 3 event-based PM subtests make up a 
very small part of the total RBMT-3 score and in most cases, the RBMT-3 score was 
not required for classification since the CDR and ACE-III were used prior to RBMT-3 




5. Conclusion & Future Work 
 
PM performance was found to be a strong indicator of day-to-day functioning in this 
study. Moreover, PM performance was also found to correlate with imaging 
biomarkers of early cognitive decline. The findings from the neuroimaging aspect of 
the study support the findings of other neuroimaging studies regarding the 
relationship between cortical thickness and PM performance (Burgess et al., 
2001;Reynolds et al., 2009). Thus, our results demonstrate cross-method 
concordance. Overall, the outcomes of this study provide a valuable insight into the 
use of PM performance as a guide to functional decline in the very early stages of 
AD. 
 
Participants will be contacted for a 1-year follow-up in which they will undertake 
another MRI scan as well as further neuropsychological assessment. One important 
additional aspect of the follow-ups is that participants will also undertake two time-
based prospective memory tasks. This will enable us to examine whether 
participants’ performance differ in time-based PM tasks compared to event-based 
ones. Furthermore, this new aspect of the study will create an opportunity to validate 
previous research by others (Troyer and Murphy, 2007;Karantzoulis et al., 2009;Hsu 
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et al., 2015), where Hsu and colleagues reported there was greater impairment in 
time-based PM performance than event-based PM tasks. The 1-year follow-ups will 
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